Results 51 to 60 of about 321,149 (261)
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
Special Libraries, July-August 1962 [PDF]
, 1962 Volume 53, Issue 6https://scholarworks.sjsu.edu/sla_sl_1962/1005/thumbnail ...
Special Libraries Association
core +2 more sources
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
ZB MED: Welchen Stellenwert hat die bibliothekarische Infrastruktur für die Wissenschaft?
GMS Medizin – Bibliothek – Information, 2016 This article deals with the expected effects of the recommendation of the senate of the Leibniz Association to the Joint Science Conference to stop the co-funding of ZB MED – Leibniz Information Centre for Life Sciences by federal and state authorities ...
Brintzinger, Klaus-Rainer
doaj +1 more source
Molecular Oncology, EarlyView.Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines
Molecular Oncology, EarlyView.The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche +8 more
wiley +1 more source
Special Libraries, February 1960 [PDF]
, 1960 Volume 51, Issue 2https://scholarworks.sjsu.edu/sla_sl_1960/1001/thumbnail ...
Special Libraries Association
core +4 more sources
Molecular Oncology, EarlyView.Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon +13 more
wiley +1 more source
Special Libraries, May-June 1957 [PDF]
, 1956 Volume 48, Issue 5https://scholarworks.sjsu.edu/sla_sl_1957/1004/thumbnail ...
Special Libraries Association
core +2 more sources
GMS Medizin – Bibliothek – InformationThe 2024 conference in Mainz is reported on and thoughts for the future development of the conference are discussed.
Jirausch, Claudia
doaj +1 more source